Milae Bioresources Co., Ltd. (KOSDAQ:218150)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,085.00
-25.00 (-1.18%)
At close: Jun 5, 2026

Milae Bioresources Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6,0196,1084,8351,9927,55218,149
Short-Term Investments
9,42410,2249,36223,26219,8409,562
Cash & Short-Term Investments
15,44316,33214,19725,25427,39227,711
Cash Growth
5.75%15.04%-43.78%-7.80%-1.15%114.03%
Accounts Receivable
8,3418,23411,9787,3868,9918,446
Other Receivables
167.0888.42141.71440.12251.3163.25
Receivables
8,5088,32312,1367,8269,2958,562
Inventory
8,2956,3646,4424,3355,1165,103
Prepaid Expenses
11.674.648.817.338.477.63
Other Current Assets
552.28566.59333.71512.98159.93139.92
Total Current Assets
32,81031,59033,11737,93541,97241,524
Property, Plant & Equipment
20,24419,67721,09811,19111,38711,436
Long-Term Investments
----2.08498.97
Goodwill
4,1614,1615,7771,2291,5861,156
Other Intangible Assets
3,0413,1423,412178.6239.66407.66
Long-Term Accounts Receivable
000-0-00
Long-Term Deferred Tax Assets
---483.05397.91157.26
Other Long-Term Assets
484.11377.58503.78573.96510.51210.88
Total Assets
60,75658,96463,90951,59156,09555,390
Accounts Payable
4,5103,6733,2081,9802,1623,290
Accrued Expenses
429.42491.57320.27209.53223.79185.73
Short-Term Debt
8,5298,3869,9312,68610,1982,322
Current Portion of Long-Term Debt
598.1598.1872.5550550-
Current Portion of Leases
184.1195.55220.39194.91246.56192.57
Current Income Taxes Payable
24.41107.12279.97-123.22-
Other Current Liabilities
1,4581,5432,0781,5061,4371,442
Total Current Liabilities
15,73214,99316,9107,12614,9417,432
Long-Term Debt
910.4711121950-14,517
Long-Term Leases
194.01234.81260.64237.74311.38338.98
Pension & Post-Retirement Benefits
463.35440.88467.427.18--
Long-Term Deferred Tax Liabilities
358.83381.42301.54---
Other Long-Term Liabilities
52.5249.3178.329.018.3742.89
Total Liabilities
17,71116,21118,2377,43015,26022,331
Common Stock
2,0422,0422,0422,0421,9901,867
Additional Paid-In Capital
22,00922,00922,00922,00919,10312,316
Retained Earnings
17,95817,46020,98921,44721,01920,057
Treasury Stock
-979.15-979.15-979.15-979.15-979.15-994.58
Comprehensive Income & Other
-389.92-144.41-475.25-365.24-387.2-359.74
Total Common Equity
40,64040,38743,58544,15340,74532,885
Minority Interest
2,4052,3662,0867.2289.36173.98
Shareholders' Equity
43,04542,75345,67244,16040,83533,059
Total Liabilities & Equity
60,75658,96463,90951,59156,09555,390
Total Debt
10,4169,52511,5033,71911,30617,370
Net Cash (Debt)
5,0286,8072,69421,53516,08610,341
Net Cash Growth
60.61%152.70%-87.49%33.88%55.56%25.57%
Net Cash Per Share
259.21349.14136.701119.39860.34583.56
Filing Date Shares Outstanding
19.1519.519.519.518.9817.74
Total Common Shares Outstanding
19.1519.519.519.518.9817.74
Working Capital
17,07816,59616,20730,80927,03134,092
Book Value Per Share
2121.652071.612235.662264.772147.251854.08
Tangible Book Value
33,43833,08434,39642,74538,92031,322
Tangible Book Value Per Share
1745.651697.001764.272192.552051.061765.94
Land
8,6088,6088,6086,1076,1076,107
Buildings
10,76810,76810,7684,2894,2894,289
Machinery
12,68012,81313,0923,9753,7603,461
Construction In Progress
1,072-486.71459.56234.2139.81